Erdal Can Alkoclar

• Head of Department at Mas Pharmaceutical Investment Corp.

BACKGROUND A Formulation consisting of 2 Dioscin and 2 Glucopyranoside Derivatives with Simultaneous GHRH Stimulative and T3 mRNA Expression Enhancimg Features. OBJECTIVE Anti Aging METHODS GH/T3 Optimization RESULTS Approved in Vitro CONCLUSIONS Endogenous GH and T3 Optimization is the an efficient method for combating age related Senility and...

A Pro-dopaminergic formulation that works via elevating cAMP expression in Substantia Nigra region and stimulating structural regeneration.

The invention is related to a composition developed for treating spinal cord injury. Current Status of Technique Spinal cord is a part of central nervous system, which extends from neck to sacrococcygeal zone in a bone structure, also referred as spine, and the cord has a central canal extending along the cord. Spinal cord controls involuntary beha...

An Anti-Asthenic Formulation designed to support Mitochondrial integrity and optimum function via elevating mitochondrial amino acid uptake and modulating interleukin levels.

The invention relates to a topical composition for increasing the speed of wound healing.

The invention is related to a nootropic composition. Current Status of Technique Recently, nootropic drugs are used to prevent cerebral cortex against hypoxia based on cerebral effects and to reinforce cognitive functions, such as memory, attention and consciousness, without exerting sedative or psychostimulating effects. Available nootropic compou...

The invention relates to a composition formed for the treatment of allergic reactions. State of the Art Histamine is a substance, which is present in most human and animal cells and causes the reactions called allergy when it goes out of the cell for various reasons. Levvis, at the experiments he conducted with histamine on animals early in this ce...

Novel Formulation with GLUT4 and GLP-1 enhancing Properties

The invention relates to a composition formed for the prevention of geriatric cachexia. State of the Art The weakness resulting from the old age may be classified by the reduction of the anaerobic capacity (muscle strength) as well as deconditioning and the structural deteriorations in the body structure. Reduction in the muscle strength and the li...

The invention relates to a hypothermic composition formed for reducing the fever. State of the Art Hypothermia is a condition in which the normal body temperature of 37°C drops below 35°C. In general, it is triggered by such conditions as exposure to rain, wind, snow or cold water. The human body performs heat exchange with its environment and is i...

The invention relates to a composition formed for the use of methylsalidroside and ginsenoside rg3 in the treatment of the alcohol addiction. State of the Art Today, tricyclic antidepressants, racetam derivatives, psychological group therapies and meetings are employed as the possible methods for the treatment of alcohol addiction. The use of antid...

The invention relates to a composition (methylprotobiocide, protopanaxatriol protopanaxadiol, Hibiscus Rosa Sinensis and Circuiligo Orchioides extracts) for the symptomatic treatment of MS and ALS diseases and the treatment of the associated neuromuscular damage.

The invention is related to a composition of ginsenoside RG3, which is developed for treating depression. Current Status of Technique Recently, available treatment modalities of depression include meditation, group therapies and drugs exerting effects over serotonin metabolism, as medications. Tricyclic antidepressants has very severe side effects,...

The invention relates to a composition formed for treating anxiety and depression.

The invention relates to a composition formed for increasing the athletic performance. State of the Art Today, the performance is involved in every field of daily life and in all the circumstances where there is interaction with the other people. Our current perception of performance is shaped by our past experiences. For a high level of performanc...

The invention relates to a protopanaxtriol composition formed for the treatment of the prostate cancer and the benign prostatic hyperplasia. State of the Art Today, the prostate cancer is a disease that occurs with the development of cancer in the prostate, which is a secretory gland associated with the male reproduction system. The cancer develops...

The invention relates to a composition formed for the treatment of attention and concentration deficit disorders. The invention relates in particular to a composition formed for the use of alpha-methyl-tyrosine ethyl ester, dimethylsalidroside and puerarin derivative for the treatment of attention and concentration deficit disorders.

The invention relates to a composition comprising dioscin derivatives and 98-E, eurycoma longifolia and cissus extracts for treating the neuroendocrinal damage caused by the autoimmune diseases.

A Formulation formulated to treat thyrogenic enzyme expression defects.

The invention relates to a composition formed for the use of low-dose isoflavones in the treatment of andropause. State of the Art For the treatment of andropause; the testosterone replacement therapy, DHEA therapy and growth hormone replacement therapy are currently employed. Testosterone therapy blocks the production of natural testosterone, supp...

The invention relates to a composition formed for the use of ginsenoside rg3 and methylprotodioscin in the treatment of the sperm production defects.